Abstract The simian varicella virus
Abstract The simian varicella virus (SVV) genome encodes ORF A, a truncated homolog of SVV ORF 4. The SVV ORF A was expressed as a 1.0-kb transcript in SVVinfected Vero cells. The ORF A promoter was active in infected Vero cells and was stimulated by the SVV immediate-early gene ORF 62 product (IE62), a viral transactivator of SVV genes. The SVV ORF A did not transactivate SVV IE, early, or late gene promoters in transfected Vero cells and was unable to augment IE62-mediated transactivation of SVV promoters. A SVV mutant lacking ORF A replicated as efficiently as wild-type SVV in infected Vero cells, indicating that ORF A expression is not essential for in vitro replication.
Simian varicella virus (SVV) induces in non-human primates a natural disease that clinically resembles human chickenpox (varicella), which is caused by varicella-zoster virus (VZV) [2, 4] . Epizootics of simian varicella, characterized by fever and vesicular skin rash, occur sporadically in facilities housing Old World monkeys [3] . Following resolution of the acute disease, SVV establishes latent infection of neural ganglia, and may subsequently reactivate to induce a secondary disease, just as VZV reactivates to cause herpes zoster [8, 9] .
SVV and VZV are genetically related, and the viral genomes are similar in size and structure and share extensive DNA homology [4] . The SVV genome encodes 69 distinct open reading frames (ORFs), each of which has homology to a corresponding VZV gene [6] . The only significant difference between the SVV and VZV genomes occurs at the genomic left end [10] . SVV DNA lacks a homolog of the VZV ORF 2, which encodes a membrane phosphoprotein that is dispensable for in vitro replication [17] . In addition, the SVV genome includes the 879-bp ORF A, which is not present in VZV DNA.
The SVV ORF A encodes a putative 293-amino-acid (aa) protein that is a truncated homolog of the 470-aa SVV ORF 4 [10] . The SVV ORF A does not include a region corresponding to the 177 aa at the amino end of SVV ORF 4 but shares 42 % aa identity with the remaining 293 aa of ORF 4. In addition, the SVV ORF A has 49 % aa identity to the homologous region of VZV ORF 4, an immediateearly (IE) gene that encodes a transactivator of VZV IE, early, and late genes and augments IE ORF 62-mediated transactivation of VZV genes [12, 13] . The function of ORF A in viral replication and pathogenesis is unknown.
The SVV ORF A is reported to be expressed in SVVinfected BSC-1 cells and in tissues of acutely infected monkeys, as detected by reverse transcription PCR [10, 11] . This study confirms and further characterizes SVV ORF A gene expression in cell culture and demonstrates that ORF A is not essential for in vitro viral replication.
The expression of an SVV ORF A transcript in SVVinfected Vero cells was demonstrated by northern blot hybridization using an ORF A DNA probe. SVV expresses a 1.0-kb ORF A RNA in SVV-infected Vero cells (Fig. 1A) . The SVV ORF 4 is expressed as a 1.4-bp transcript, as detected using an ORF 4-specific DNA probe. The ORF A probe did not detect the ORF 4 transcript in infected cells when stringent hybridization conditions were used.
SVV ORF A gene expression was further characterized by analysis of ORF A promoter activity. Initially, 326 bp upstream of the ORF A ATG start codon was cloned into the pGL3 vector (Promega Corp.) at a site upstream of the luciferase reporter gene. This SVVORFApr-pGL3 DNA construct was used to transfect Vero cell monolayers, and luciferase activity was determined in cell lysates at 48 h post-transfection. The results showed that the SVV ORF A promoter is active in SVV-infected Vero cells, but not in uninfected Vero cells (Fig. 1B) .
The ORF A promoter is stimulated by the SVV ORF 62 IE gene product (IE62), a major viral transactivator of SVV IE, early, and late genes, as indicated by co-transfection of Vero cells with SVVORFApr-pGL3 and pCI-IE62, which results in expression of SVV IE62 from a human cytomegalovirus promoter/enhancer (Fig. 1C) [7, 14] . The essential sequences of the ORF A promoter required for IE62 stimulation were identified by promoter deletion analysis. Deletion of 127 bp (bp 199-326 upstream of the ATG start site, SVVORFA(2)pr-pGL3) resulted in a fivefold reduction in ORF A promoter activity (Fig. 1D) . Analysis of this sequence identified putative binding sites for transcription factors known to stimulate SVV and VZV genes, including USF (located beginning at bp -314 relative to the ATG start site) and SP1 (bp -202) [14] [15] [16] . Deletion of 252 bp (bp 74-326 bp upstream of the ATG start site, SVVORFA(3)pr-pGL3) resulted in additional reduction of ORF A promoter activity, potentially due to the loss of a putative TATA binding site at -183 bp upstream of the ATG start site. The results indicate that sequences between 74 and 326 bp upstream of the ATG start site are critical for IE62-mediated transactivation of the ORF A promoter.
The ability of the ORF A protein expressed from an HCMV promoter to transactivate other SVV promoters in transfected Vero cells was evaluated using a luciferase reporter assay. As a positive control, the SVV IE62 strongly transactivated the SVV ORF 29 early gene promoter ( Fig. 2A) . In addition, the SVV IE62 transactivated its own ORF 62 IE promoter and the glycoprotein E (gE, ORF 68) late gene promoter (data not shown). In contrast, the SVV ORF A was not able to transactivate the SVV ORF 29 promoter (Fig. 2A) or the ORF 62 or gE promoters (data not shown) under the same conditions. In addition, the ORF A product was not able to augment SVV IE62-mediated transactivation of the SVV ORF 29 promoter in Vero cells co-transfected with pCI-ORF A and pCI-IE62 (Fig. 2B) . The SVV ORF 4 was a weak transactivator of the SVV ORF 29 promoter (twofold, but not statistically Fig. 2A ), but was able to significantly stimulate IE62-mediated transactivation of the ORF 29 promoter (Fig. 2B) .
The inability of the SVV ORF A to transactivate SVV promoters may be related to the lack of an amino terminus corresponding to the VZV ORF 4, which has been shown to be critical for VZV ORF 4 transactivation of VZV promoters and for augmenting IE62 transactivation [13] . In addition, the SVV ORF A lacks a nuclear localization signal that is essential for VZV ORF 4 transactivation [10] .
To determine the importance of the SVV ORF A for viral replication in cell culture, ORF A was deleted from the SVV genome using the SVV cosmid system combined with the recA-assisted restriction endonuclease cleavage method (RARE) [1, 5] . PCR analysis employing primers flanking ORF A confirmed deletion of 754 bp (SVV nt 1715-2468) from within the 879-bp SVV ORF A (nt 1573-2452) plus 16 upstream bp (Fig. 3A) . Viral growth analysis demonstrated that SVVORFAdel replicated as efficiently as wild-type SVV in infected Vero cells (Fig. 3B) . In addition, the median viral plaque size for SVVorfAdel (0.50 ± 0.06 mm) was similar to that of wild-type SVV (0.48 ± 0.08 mm) based on plaque diameter in CV-1 cell monolayers at 72 h postinfection.
This study demonstrates that the SVV ORF A gene is expressed in acutely infected Vero cells as a 1.0-kb transcript and is actively stimulated by the SVV IE62 transactivator. However, ORF A expression is not essential for efficient viral replication in cell culture. The results do not support ORF A as a viral transactivator of other SVV genes, and the function of ORF A in viral replication is unknown. While ORF A may be a consequence of a truncated duplication of ORF 4, the conservation of this gene within various SVV isolates derived from widespread epizootics suggests a role in viral pathogenesis [10] . SVV ORF A is expressed in tissues of acutely infected monkeys [10, 11] . In addition, ORF A transcripts were detected in 3 of 16 neural ganglia derived from latently infected rhesus monkeys [11] . Further study of the SVVORFAdel mutant in the simian varicella model may be useful in determining the role of the SVV ORF A in viral pathogenesis, latency, and reactivation.
